在癌症中UHRF1的翻译后修改的作用
Lili Gu1,2,3, Yongming Fu1,2,3, Xiong Li4,5,6,7
1Key Laboratory of Clinical Precision Pharmacy of Guangdong Higher Education Institutes, The First Affiliated Hospital, Guangdong Pharmaceutical University, Guangzhou, 510699, Guangdong, China.
Epigenetics & chromatin
|May 9, 2024
概括
一种表观遗传调节剂UHRF1在许多癌症中过度表达,通过抑制瘤抑制剂而起瘤基因作用. 了解其翻译后修改 (PTMs) 是开发新癌症疗法的关键.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- UHRF1是一种E3泛素酶和表观遗传调节剂,参与DNA复制,甲基化和修复.
- 异常的UHRF1过度表达在十多种癌症类型中很常见,将其确定为一个重要的瘤基因.
- UHRF1通过DNMT1-介导的DNA甲基化来抑制CDKN2A,BRCA1和CDH1等瘤抑制基因.
研究的目的:
- 综合审查UHRF1翻译后修改 (PTM) 的类型.
- 要总结UHRF1 PTMs的生物功能.
- 突出了解UHRF1 PTMs对于开发向抗癌疗法的重要性.
主要方法:
- 对UHRF1.0现有研究的文献综述.
- 对UHRF1.1报告的翻译后修改的分析.
- 综合这些修改对功能影响的信息.
主要成果:
- UHRF1 PTM包括酸化,乙化,甲基化和无处不在.
- 这些修改调节了UHRF1的蛋白质稳定性,局部化和相互作用.
- 最近已经确定了UHRF1的新型PTM,尽管机制需要进一步阐明.
结论:
- 在其致癌功能中,UHRF1 PTM 起着至关重要的作用.
- 对UHRF1 PTM的彻底理解对于未来的抗癌药物开发至关重要.
- 准UHRF1 PTM为新型癌症疗法提供了一个有希望的途径.
更多相关视频
相关概念视频
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
The Unfolded Protein Response
4.6K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.6K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Regulation of Expression at Multiple Steps
893
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
893
Negative Regulator Molecules
35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K


